We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current DIM market cap is 16.26B. The company's latest EPS is EUR 3.1819 and P/E is 52.56.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 1.44B | 1.91B | 2.89B | 3.49B | 2.78B |
| Operating Income | 334.89M | 470M | 854.78M | 1.04B | 462.5M |
| Net Income | 234.5M | 335.93M | 414.41M | 876.1M | 309.7M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 1.85B | 2.86B | 3.95B | 5.07B | 7.74B |
| Total Liabilities | 656.48M | 1.4B | 2.22B | 2.55B | 5.07B |
| Total Equity | 1.19B | 1.46B | 1.73B | 2.51B | 2.67B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 310.13M | 416.88M | 695.97M | 612.3M | 746.4M |
| Investing | -184.37M | -621.12M | -465.23M | -957.5M | -2.72B |
| Financing | -122.16M | 234.07M | -71.71M | 220.7M | 1.99B |
| Market Cap | 16.26B |
| Price to Earnings Ratio | 52.56 |
| Price to Sales Ratio | 5.87 |
| Price to Cash Ratio | 139.61 |
| Price to Book Ratio | 6.09 |
| Dividend Yield | 0.41% |
| Shares Outstanding | 97.33M |
| Average Volume (1 week) | 70.04k |
| Average Volume (1 Month) | 63.61k |
| 52 Week Change | -16.39% |
| 52 Week High | 281.00 |
| 52 Week Low | 139.10 |
| Spread (Intraday) | 0.1 (0.06%) |
| Company Name | Sartorius Stedim Biotech SA |
| Address |
zone industrielle les paluds avenue de jouques marseille, bouches-du-rhone 13781 |
| Website | https://www.sartorius.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
